Mentice Dirección

Dirección controles de criterios 1/4

El CEO de Mentice's es Göran Malmberg, nombrado en Mar 2008, tiene una permanencia de 16.25 años. posee directamente un 2.78% de las acciones de la empresa, con un valor de €1.72M. La antigüedad media del equipo directivo y de la junta directiva es de 0.8 años y 4.8 años, respectivamente.

Información clave

Göran Malmberg

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	16.3yrs
Participación del CEO	2.8%
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	4.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Göran Malmberg en comparación con los beneficios de Mentice?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-kr26m
Dec 31 2023	n/a	n/a	-kr3m
Sep 30 2023	n/a	n/a	kr2m
Jun 30 2023	n/a	n/a	-kr6m
Mar 31 2023	n/a	n/a	-kr25m
Dec 31 2022	n/a	n/a	-kr31m
Sep 30 2022	n/a	n/a	-kr37m
Jun 30 2022	n/a	n/a	-kr36m
Mar 31 2022	n/a	n/a	-kr24m
Dec 31 2021	kr4m	kr4m	-kr29m
Sep 30 2021	n/a	n/a	-kr22m
Jun 30 2021	n/a	n/a	-kr15m
Mar 31 2021	n/a	n/a	-kr21m
Dec 31 2020	kr4m	kr3m	-kr13m
Sep 30 2020	n/a	n/a	-kr9m
Jun 30 2020	n/a	n/a	-kr17m
Mar 31 2020	n/a	n/a	-kr17m
Dec 31 2019	kr6m	kr5m	-kr21m

Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Göran es razonable en comparación con empresas de tamaño similar en el mercado German.

Compensación vs. Ingresos: La compensación de Göran ha aumentado mientras la empresa no es rentable.

CEO

Göran Malmberg (65 yo)

16.3yrs

Permanencia

kr4,465,000

Compensación

Mr. Goran Malmberg serves as Group Chief Executive Officer and President at Mentice AB. Mr. Malmberg had been the Chief Executive Officer and President of Mentice AB since March 2008. Mr. Malmberg has exte...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Göran Malmberg	Group CEO & President	16.3yrs	kr4.47m	2.78% SEK 1.7m
Ulrika Voksepp	Chief Financial Officer	less than a year	sin datos	sin datos
Jonatan Sjostrom	Chief Operating Officer	less than a year	sin datos	sin datos
Henrik Storm	Chief Technology Officer	9.4yrs	sin datos	sin datos
Martin Harris	Vice President of Marketing & Sales Enablement	less than a year	sin datos	sin datos
Matar Dakhil	Executive Vice President of Business Development	no data	sin datos	0.60% SEK 369.4k
Stacy Hammar	Corporate Marketing Manager of Medical Device	no data	sin datos	sin datos
Dominic Steffel	Senior Product Manager	no data	sin datos	sin datos

0.8yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de MN2 no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Gosta Johannesson	Director	4.8yrs	kr170.00k	sin datos
Denis Gestin	Independent Director	4.8yrs	kr170.00k	sin datos
Lawrence Howell	Director	13.4yrs	sin datos	33.99% SEK 21.0m
Eola Runsten	Independent Director	4.1yrs	kr170.00k	sin datos
David Ballard	Independent Director	4.8yrs	kr170.00k	sin datos
Johann Koss	Independent Director	9.4yrs	kr100.00k	sin datos
Magnus Nilsson	Independent Chairman of the Board	1.5yrs	kr360.00k	sin datos

4.8yrs

Permanencia media

65yo

Promedio de edad

Junta con experiencia: La junta directiva de MN2 se considera experimentada (4.8 años de antigüedad promedio).

Mentice Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Director recently bought €71k worth of stock

Mentice (publ) Appoints Ulrika Drotz Voksepp as New Chief Financial Officer, Effective January 2, 2024

Mentice AB (Publ) Announces Board Appointments

Mentice AB (publ), Annual General Meeting, May 23, 2024

Mentice AB (Publ) Appoints of Jonatan Sjöström to Its Executive Management Group as Chief Operating Officer, Effective from September 14, 2023

Mentice AB (publ) Announces Chief Financial Officer Changes

Recent updates

Full year 2023 earnings released: kr0.11 loss per share (vs kr1.22 loss in FY 2022)

Mentice AB (publ) to Report Fiscal Year 2023 Final Results on Apr 24, 2024

Full year 2023 earnings released: kr0.11 loss per share (vs kr1.22 loss in FY 2022)

New minor risk - Market cap size

New major risk - Share price stability

Mentice Receives FDA 510(K) Clearance for Ankyras

Mentice Receives FDA 510(K) Clearance for Ankyras

Mentice AB (publ) (OM:MNTC) agreed to acquire All substantial assets of Biomodex from SIMARATO SAS for €0.2 million.

Director recently bought €71k worth of stock

Mentice (publ) Appoints Ulrika Drotz Voksepp as New Chief Financial Officer, Effective January 2, 2024

Mentice AB (Publ) Announces Board Appointments

Third quarter 2023 earnings released

Mentice AB (publ), Annual General Meeting, May 23, 2024

Mentice AB (publ) to Report First Half, 2024 Results on Jul 23, 2024

Mentice AB (Publ) Appoints of Jonatan Sjöström to Its Executive Management Group as Chief Operating Officer, Effective from September 14, 2023

New minor risk - Market cap size

Mentice AB (publ) Announces Chief Financial Officer Changes

Second quarter 2023 earnings released: EPS: kr0.06 (vs kr0.72 loss in 2Q 2022)

Insufficient new directors

Mentice AB (publ) Announces Resignation of Gunilla Andersson as Chief Financial Officer

Full year 2022 earnings released: kr1.22 loss per share (vs kr1.18 loss in FY 2021)

Full year 2022 earnings released: kr1.22 loss per share (vs kr1.18 loss in FY 2021)

Third quarter 2022 earnings released: kr0.30 loss per share (vs kr0.29 loss in 3Q 2021)

Mentice AB (publ) to Report First Half, 2023 Results on Jul 20, 2023

Mentice AB (publ), Annual General Meeting, May 11, 2023

Second quarter 2022 earnings released: kr0.71 loss per share (vs kr0.22 loss in 2Q 2021)

Mentice AB (publ) to Report Q4, 2022 Results on Feb 09, 2023

Mentice AB (publ) (OM:MNTC) completed the acquisition of All assets of the Ankyras software suite from Galgo Medical SL.

Mentice AB (publ) (OM:MNTC) agreed to acquire All assets of the Ankyras software suite from Galgo Medical SL for €2.775 million.

First quarter 2022 earnings released: kr0.30 loss per share (vs kr0.50 loss in 1Q 2021)

High number of new directors

Mentice AB (publ) Announces Change of Chairman of Board, Effective December 30, 2022

High number of new directors

Mentice Appoints Jan Grund Pedersen as New Vice President of Strategic Alliances & Business Development

Mentice AB (publ) to Report Fiscal Year 2021 Results on Apr 06, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: kr0.29 loss per share (vs kr0.014 loss in 3Q 2020)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Chief Financial Officer Elisabet Lund has left the company

Second quarter 2021 earnings released: kr0.22 loss per share (vs kr0.46 loss in 2Q 2020)

Less than half of directors are independent

Second quarter 2021 earnings released: kr0.22 loss per share (vs kr0.46 loss in 2Q 2020)

First quarter 2021 earnings released: kr0.50 loss per share (vs kr0.21 loss in 1Q 2020)

New 90-day low: €7.52

Full year 2020 earnings released: kr0.54 loss per share (vs kr1.05 loss in FY 2019)

Revenue misses expectations

Mentice Announces Executive Appointments

Mentice AB (publ) to Report Fiscal Year 2020 Results on Feb 04, 2021

Third quarter 2020 earnings released: kr0.01 loss per share

Revenue misses expectations

Mentice AB (Publ) Announces Nomination Committee

New 90-day low: €7.00

Mentice AB (publ) (OM:MNTC) entered into agreement to acquire substantially all assets of EQIP, Inc. for $0.25 million.

Mentice AB (publ) (OM:MNTC) signed a definitive agreement to acquire Substantial All Assets of Vascular Simulations LLC for $6 million.

Mentice AB (publ) to Report Q2, 2020 Results on Aug 13, 2020

Mentice AB (publ) to Report Q3, 2020 Results on Nov 12, 2020

New 90-day high - €7.36

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad